ABSTRACT:
Transdermal route of drug delivery is a promising substitute to oral-systemic delivery of drug substances. It offers several benefits such as avoidance of first pass metabolism, patience compliance, ease of application and so on. But along with these benefits, the major drawback is the barrier function of the skin which hinders the transdermal delivery of the drugs. Hence, ethosomes are useful in such conditions as they surpass the barriers of the skin. Ethosomes are the noninvasive delivery carriers that enable drugs to reach deep into the skin layers or the systemic circulation. They are made up of phospholipids, high concentration of ethanol and water. Ethosomes are able to encapsulate and distribute extremely lipophilic molecules through the skin, as well as cationic drugs, due to their unique structure and deliver them to the deep layers of the skin. Ethosomes have become an area of research interest, because of its enhanced skin permeation, improved drug delivery, increased drug entrapment efficiency etc. This review article provides an insight about the ethosomal systems, their mechanism of penetration into the skin, methods of preparation, evaluation and applications in the field of pharmacy.
Cite this article:
Saloni Bhandari. Ethosomes: A Novel Vesicular Innovation to Enhance Transdermal Delivery of Drugs. Research Journal of Pharmaceutical Dosage Forms and Technology.2022; 14(1):72-8. doi: 10.52711/0975-4377.2022.00012
Cite(Electronic):
Saloni Bhandari. Ethosomes: A Novel Vesicular Innovation to Enhance Transdermal Delivery of Drugs. Research Journal of Pharmaceutical Dosage Forms and Technology.2022; 14(1):72-8. doi: 10.52711/0975-4377.2022.00012 Available on: https://rjpdft.com/AbstractView.aspx?PID=2022-14-1-12
REFERENCES:
1. Abdulbaqi IM, Darwis Y, Khan NA and Khan RA. Ethosomal Nanocarriers: The Impact of Constituents and Formulation Techniques on Ethosomal Properties, In vivo Studies, And Clinical Trials. International Journal of Nanomedicine. 2016; 11: 2279–2304.
2. Monisha C, GNK Ganesh, Mythili L and Kayalvizhi Radhakrishnan. A Review on Ethosomes for Transdermal Application. Research J. Pharm. and Tech. 2019; 12(7): 3133-3143.
3. Jadhav KP, Kundan A, Kapadnis K, Shinkar D, Pathan V and Jadhav A. Ethosomes as Novel Drug Delivery System: A Review. Int. J. Pharm. Sci. Rev. Res. 2000; 62(1): 173-182.
4. Meesa Rajender, et al, Ethosomes as Novel Drug Delivery Carriers – A Review, Indo Am. J. P. Sci, 2016; 3(12): 1639-1643.
5. Garg V, Singh H, Bimbrawh S, et al. Ethosomes and Transfersomes: Principles, Perspectives and Practices Current Drug Delivery. 2017; 14: 613-633
6. Wadher KJ, Shital D, Pounikar SD, Trivedi SS and Umekar MJ. Ethosome: A Novel Vesicular Carrier International Journal of Innovative Research and Advanced Studies (IJIRAS) 2018; 5(7): 13-20.
7. Finnin BC and Morgan TM. Transdermal Penetration Enhancers: Applica¬tions, Limitations, and Potential. J Pharm Sci. 1999; 88(10): 955–958.
8. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes- Novel Vesicular Carriers for Enhanced Delivery: Characterization and Skin Pen¬etration Properties. J Control Release. 2000; 65(3): 403–418.
9. Puri R and Jain S. Ethogel Topical Formulation For Increasing The Local Bioavail¬ability Of 5-Fluorouracil: A Mechanistic Study. Anticancer Drugs. 2012; 23(9): 923–934.
10. Rao Y, Zheng F, Zhang X, Gao J and Liang W. In vitro Percutaneous Per¬meation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers. AAPS Pharmscitech. 2008; 9(3): 860–865.
11. Dayan N and Touitou E. Carriers for Skin Delivery of Trihexypheni¬dyl Hcl: Ethosomes Vs Liposomes. Biomaterials. 2000; 21(18): 1879–1885.
12. Limsuwan T and Amnuaikit T. Development of Ethosomes Containing Mycophenolic Acid. Procedia Chem. 2012; 4: 328–335.
13. Liu X, Liu H, Liu J, et al. Preparation of a Ligustrazine Ethosome Patch and its Evaluation In vitro and In vivo. Int J Nanomedicine. 2011; 6: 241–247.
14. Paolino D, Lucania G, Mardente D, Alhaique F and Fresta M. Ethosomes for Skin Delivery of Ammonium Glycyrrhizinate: In vitro Percutaneous Permeation through Human Skin and In vivo Anti-Inflammatory Activity on Human Volunteers. J Control Release. 2005; 106(1–2): 99–110.
15. Zhaowu Z, Xiaoli W, Yangde Z and Nianfeng L. Preparation of Matrine Ethosome, its Percutaneous Permeation In vitro and Anti-Inflammatory Activity In vivo in Rats. J Liposome Res. 2009; 19(2): 155–162.
16. López-Pinto JM, González-Rodríguez ML and Rabasco AM. Effect of Choles¬terol and Ethanol on Dermal Delivery from DPPC liposomes. Int J Pharm. 2005; 298(1): 1–12.
17. Maestrelli F, Capasso G, Gonzalez-Rodriguez ML, Rabasco AM, Ghelardini C and Mura P. Effect of Preparation Technique on the Properties and In vivo Efficacy of Benzocaine-Loaded Ethosomes. J Liposome Res. 2009; 19(4): 253–260.
18. Zhang JP, Wei YH, Zhou Y, Li YQ and Wu XA. Ethosomes, Binary Etho¬somes and Transfersomes of Terbinafine Hydrochloride: A Comparative Study. Arch Pharm Res. 2012; 35(1): 109–117.
19. Li G, Fan Y, Fan C, et al. Tacrolimus-Loaded Ethosomes: Physicochemical Characterization and In vivo Evaluation. Eur J Pharm Biopharm. 2012; 82(1): 49–57.
20. Nidhi Nainwal, Sunil Jawla, Ranjit Singh and Vikas Anand Saharan. Transdermal Applications of Ethosomes-A Detailed Review. Journal of Liposome Research. 2018; DOI: 10.1080/08982104.2018.1517160
21. Pawar P, Kalamkar R, Jain A and Amberkar S. Ethosomes: A Novel Tool for Herbal Drug Delivery, International Journal of Pharmacy and Pharmaceutical Research. 2015; 3(4): 191-202.
22. Aggarwal D and Nautiyal U. Ethosomes: A review. International Journal of Pharmaceutical and Medicinal Research. 2016; 4(4): 354-63.
23. Transdermal Delivery of Ciclopirox Olamine via Ethosomal and Liposomal Carrier, Research Journal of Pharmacy and Technology. 2011; 4(8):1207–11.
24. Fan C, Li X, Zhou Y, Zhao Y, Ma S, Li W et al. Enhanced Topical Delivery of Tetrandrine by Ethosomes for Treatment of Arthritis. Biomed Res Int. 2013.
25. Tiwari RK, Chauhan NS and Yogesh HS. Ethosomes: A Potential Carries for Transdermal Drug Delivery. Int. J. Drug Dev. and Res. 2010; 2(2): 448-452.
26. Heeremans JLM, Gerristen HR, Meusen SP, et al. The Preparation of Tissue Type Plasminogen Activator (T- PA) Containing Liposomes: Entrapment Efficacy and Ultracentrifugation Damage. Journal of Drug Targeting. 1995; 3: 301.
27. Pakhale NV, Gondkar SB and Saudagar RB. Ethosomes: Transdermal Drug Delivery System, Journal of Drug Delivery and Therapeutics. 2019; 9(3): 729-733.
28. Touitou E. Inventor and Assignee. Compositions for Applying Active Substances to or through the Skin. United States Patent US 5540934 A. 1996 Jul 30.
29. Mishra KK, Kaur CD, Verma S, et al. Chapter 2: Transethosomes and Nanoethosomes: Recent Approach on Transdermal Drug Delivery System. 32-54. Intechopen. http://dx.doi.org/10.5772/intechopen.81152
30. Ashoniya S and Meenakshi C. Ethosomes as Vesicular Carrier for Enhanced Transdermal Delivery of Ketoconazole – Formulation and Evaluation. J Pharm Cosmetol. 2011; 1(3): 1–14.
31. R.B. Saudagar, S. Samuel. Ethosomes: Novel noninvasive carrier for Transdermal Drug Delivery. Asian J. Pharm. Tech. 2016; 6(2): 135-138. doi: 10.5958/2231-5713.2016.00019.2
32. Maghraby GM, Williams AC and Barry BW. Oestradiol Skin Delivery from Ultra Deformable Liposomes: Refinement of Surfactant Concentration, International Journal of Pharmaceutics. 2000: 63-74.
33. Roge Ashish B, Sakhare Ram S, Bakal RL, Channawar MA, Bakde BV, Gawande SR , Chandewar AV. Ethosomes: Novel Approach in Transdermal Drug Delivery System. Research J. Pharma. Dosage Forms and Tech. 2010; 2(1): 23-27.
34. Mahmood S, Mandal UK and Chatterjee B. Transdermal Delivery of Raloxifene HCl via Ethosomal System: Formulation, Advanced characterizations and Pharmacokinetic Evaluation. Int J Pharm. 2018; 542(1–2): 36–46.
35. Jaiswal PK, Kesharwani S, Kesharwani R and Patel DK. Ethosome: A New Technology used as Topical and Amp; Transdermal Delivery System. J Drug Deliv Ther. 2016; 6(3):6–17.
36. Garg BJ, Garg NK, Beg S, Singh B and Katare OP. Nanosized Ethosomes-Based Hydrogel Formulations of Methoxsalen for Enhanced Topical Delivery against Vitiligo: Formulation Optimization, In vitro Evaluation and Preclinical Assessment. J Drug Target. 2016; 24(3): 233–46.
37. Mbah C, Builders P, Nzekwe I, Kunle O, Adikwu M, and Attama A. Formulation and In vitro Evaluation of pH-Responsive Ethosomes for Vaginal Delivery of Metronidazole. Journal of Drug Delivery Science and Technology. 2014; 24(6): 565-571.
38. Kadam NV, Mahajan VR. Ethosomes: A Novel Drug Carrier. Res. J. Topical and Cosmetic Sci. 2013; 4(1): 84-91.
39. Touitou E. Compositions for Applying Active Substances to or Through the Skin, US Patent: 5538,934,19.
40. Fry DW, White JC and Goldman ID. Rapid Secretion of Low Molecular Weight Solutes from Liposomes without Dilution, Analytical Biochemistry 1978; 90: 809-815.
41. New RC. Preparation of liposomes and Size Determination, In: Liposomes A Practical Approach, New RRC (Ed.), Oxford University Press Oxford 1990: 36-3.
42. Cevc G, Schatzlein A and Blume G. Transdermal Drug Carriers: Basic Properties, Optimization and Transfer Efficiency in case of Epicutaneously Applied Peptides, Journal of Controlled Release 1995; 36: 3-16.
43. Berge V, Swartzendruber VB and Geest J. Development of an Optimal Protocol for the Ultrastructural Examination of Skin by Transmission Electron Microscopy, Journal of Microscopy 1997; 187(2):125-133.
44. Toll R, Jacobi U, Richter H, Lademann J, Schaefer H and Blume U. Penetration Profile of Microspheres in Follicular Targeting of Terminal Hair Follicles, Journal of Investigative Dermatology 2004; 123: 168-176.
45. Pratima NA and Tiwari S. Ethosomes: A Novel Tool for Transdermal Drug Delivery, International Journal of Research in Pharmacy and Sciences. 2012; 2(1):1-20.
46. Celia C, Cilurzo F, Trapasso E, Cosco D, Fresta M and Paolino D. Ethosomes and Transfersomes Containing Linoleic Acid: Physicochemical and Technological Features of Topical Drug Delivery Carriers for the Potential Treatment of Melasma Disorders, Biomedical Microdevices. 2011; 6: 105-111.
47. Patel A, Sharma RK, Trivedi M. Ethosomes: A Novel Tool for Transdermal Drug Delivery. Research J. Pharm. and Tech. 2013; 6(8): -841.
48. Maxwell A, Priya S. Nanosized Ethosomes – A Promising Vesicular Drug Carrier for Transdermal Drug Delivery. Research J. Pharm. and Tech 2019; 12(2):876-880. doi: 10.5958/0974-360X.2019.00150.1
49. Jose J, Shetty S, Sandeep DS, Nayak P. Ethosomes as a Promising Delivery Carrier for Herbal Drugs: Recent Developments. Research J. Pharm. and Tech 2018; 11(7): 3197-3200. doi: 10.5958/0974-360X.2018.00587.5 https://rjptonline.org/AbstractView.aspx?PID=2018-11-7-86
50. Singh Shikha Y., Aher Smita S., Saudagar Ravindra B. Ethosomes –Novel Drug Delivery System. Research J. Topical and Cosmetic Sci. 2015; 6(1): 7-14.
51. Kesharwani R, Patel DK, Sachan A, Kumar V, Mazumdar B. Ethosomes: A Novel Approach for Transdermal and Topical Drug Delivery. Research J. Topical and Cosmetic Sci. 2015; 6(1): 15-20. doi: 10.5958/2321-5844.2015.00003.5